Tamil Nadu's TN-KET Program Achieves 38% Drop in TB Deaths
A recent study highlights the success of Tamil Nadu's TN-KET initiative in significantly reducing tuberculosis mortality rates.
The TN-KET program led to a 38% reduction in TB deaths in Tamil Nadu.
The initiative focuses on five key health assessments to identify severely ill patients.
The program's framework can serve as a model for other states and countries facing high TB burdens.
A study published in BMJ Global Health reveals that Tamil Nadu's TN-KET initiative has successfully reduced tuberculosis (TB) deaths by 38%. This state-specific program, which began in April 2022 and concluded in December 2025, employs a streamlined screening process to identify critically ill patients and prioritize their care in hospitals. The findings indicate that the initiative has made a significant impact on public health in the region, offering insights for other states aiming to combat TB-related fatalities.
The TN-KET program, officially known as Tamil Nadu Kasanoi Erappila Thittam, is the first of its kind in India, focusing on differentiated TB care. The study noted that the death rate from TB, which had a baseline of 6.3%, saw a substantial relative reduction among patients diagnosed between July 2024 and December 2025. Researchers emphasized that even in a state with robust public health systems, it took two years to effectively translate triaging efforts into a measurable decrease in TB mortality.
The initiative targets adults aged 15 and older diagnosed with drug-sensitive TB, with approximately 60,000 patients eligible for screening annually. Health workers assess five critical parameters: body mass index (BMI), pedal edema, respiratory rate, oxygen saturation, and the ability to stand unaided. Those classified as severely ill based on these criteria are prioritized for hospital referrals, ensuring they receive timely medical attention. The researchers chose these five parameters for their simplicity, making them easier for health workers to implement in routine healthcare settings.
The implications of TN-KET extend beyond Tamil Nadu, as the program's monitoring and evaluation framework could inform TB care strategies in other high-burden regions. The study highlighted that a significant proportion of TB deaths occurred shortly after diagnosis, underscoring the need for immediate identification and care of severely ill patients. The program also achieved notable improvements in patient management, with the percentage of patients successfully discharged for continued treatment increasing from 79% to 97% over the study period.
Looking ahead, the researchers noted challenges in follow-up assessments, particularly for high-risk patients, which limited the ability to track improvements in their health. They cautioned against the complexity of national guidelines that require extensive assessments, advocating instead for a focus on simpler, more practical evaluation methods. The success of TN-KET could pave the way for similar initiatives in other states, emphasizing the importance of early identification and timely intervention in reducing TB mortality rates.




